Veracyte, Inc.: Revision history

20 August 2022

• curprev 23:1223:12, 20 August 2022 95.149.241.133 talk 1,183 bytes +11 No edit summary undo

14 August 2022

• curprev 11:4011:40, 14 August 2022 109.180.50.163 talk 1,172 bytes +15 No edit summary undo

31 July 2022

• curprev 15:1215:12, 31 July 2022 >Chris 1,157 bytes +1,157 Created page with "Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis..."